Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...

The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...

Scientists in Japan have used CRISPR gene-editing technology to remove the extra chromosome that causes Down syndrome.

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

Investing.com -- CRISPR Therapeutics (NASDAQ: CRSP) reported a wider-than-expected loss for the second quarter of 2025, sending shares down 6.1% as both earnings and revenue fell significantly short ...

CRISPR Therapeutics (CRSP) recently announced significant developments in its in vivo cardiovascular disease programs, notably CTX310 and CTX320, which may have contributed to the company's 47% share ...

Crispr (Clustered Regularly Interspaced Short Palindromic Repeats) is a new biotechnology that allows the editing of genes, with applications including potentially curing genetic conditions such ...

Biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP) isn't a name on many investors' radar -- and understandably so. Its ...

Scientists have found a way to genetically modify mosquitoes so they cannot pierce human skin—disabling their ability to bite ...